Seagen
SGEN
#574
Rank
A$61.86 B
Marketcap
A$327.92
Share price
-0.07%
Change (1 day)
57.70%
Change (1 year)

Seagen (SGEN) - Net assets

Net assets on the balance sheet as of September 2023 : A$3.65 Billion

According to Seagen 's latest financial reports the company has A$3.65 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Seagen - Net assets on balance sheet (from 2001 to 2023)

Net assets by year

Year Net assets Change
2022-12-31$A$4.12 B-2.55%
2021-12-31$A$4.22 B-6.8%
2020-12-31$A$4.53 B69.27%
2019-12-31$A$2.67 B48.19%
2018-12-31$A$1.80 B108.36%
2017-12-31$A$0.86 B-1.34%
2016-12-31$A$0.87 B-6.57%
2015-12-31$A$0.94 B265.48%
2014-12-31$A$0.25 B-0.17%
2013-12-31$A$0.25 B18.58%
2012-12-31$A$0.21 B1.96%
2011-12-31$A$0.21 B34.23%
2010-12-31$A$0.15 B-30.73%
2009-12-31$A$0.22 B104.95%
2008-12-31$A$0.11 B81.38%
2007-12-31$A$61.74 M-44.83%
2006-12-31$A$0.11 B8.54%
2005-12-31$A$0.10 B-23.14%
2004-12-31$A$0.13 B33.2%
2003-12-31$A$0.10 B21.53%
2002-12-31$A$82.89 M-30.27%
2001-12-31$A$0.11 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
A$129.60 B 3,444.67%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-A$9.48 Billion-359.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$26.73 B 631.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$28.81 B 688.18%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$33.07 B 804.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
A$38.42 M-98.95%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
A$0.80 B-77.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$0.65 B-82.11%๐Ÿ‡บ๐Ÿ‡ธ USA